ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2024

Abstract Number: 2218

Association Between Frailty and Peri-Operative Inpatient Adverse Outcomes Among Patients with and Without Rheumatoid Arthritis

Ali Yazdanyar1, Joshua Baker2, Katherine Wysham3 and Michael Ward4, 1Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 2Department of Medicine, Perelman School of Medicine University of Pennsylvania, Philadelphia, PA, 3VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA, 4NIH, Bethesda, MD

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2024

Keywords: Outcome measures, rheumatoid arthritis, surgery

Session Information

Date: Monday, November 18, 2024

Title: RA – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Frailty is a state reflecting a reduced physiologic reserve.  There is accumulating literature on the prevalence and clinical significance of frailty in Rheumatoid Arthritis (RA).  A hospitalization with an in-hospital procedure represents a period of heightened stress posing a higher risk of adverse events. There is lack of evidence on the prevalence and prognostic significance of frailty in RA in the inpatient perioperative setting. We sought to assess the association between frailty and peri-procedure adverse outcomes.

Methods: We conducted a cross sectional study using data from the 2019 and 2020 National Inpatient Sample (NIS). Included were hospitalizations among ages ≥18 years who underwent a major diagnostic or therapeutic non-cardiac procedure and were discharged alive, and who underwent a major diagnostic or therapeutic non-cardiac procedure. Frailty was measured by the Hospital Frailty Risk Score (HFRS). RA status, procedures, comorbid diagnoses, and the HFRS were defined using International Classification of Diseases, Tenth Revision (ICD-10) codes.  Procedures were categorized into low, intermediate, or high-risk using published guidelines.  Outcomes of interest were all-cause inpatient mortality, adverse clinical events (ACE), and a need for higher discharge healthcare resources. ACE included the presence of myocardial infarction, acute congestive heart failure, major cardiac arrhythmia, deep venous thrombosis or pulmonary embolism, acute kidney injury, or wound infections. The discharge healthcare needs (DHN) was defined as need for skilled facility, home health. Logistics regression provided the Odds Ratio (OR) (RA vs. non RA) in both unadjusted [uOR] and adjusted for HFRS [aOR] models. 

 

Results: Of the 9,979,407 hospitalizations, 1.9% had RA. RA patients were older (65.5 vs 54.4) and more likely to be women (74.7% vs 65.1%). Overall, 22.9% (RA vs non RA: 2.7% vs 23.4%) underwent low, 69.6% (RA vs non RA: 89.7% vs 68.3%) intermediate, and 7.4% (RA vs non RA: 7.7% vs 7.4%) high risk procedures. 
Patients were more likely to have higher HFRS (Figure 1).  Table 1 displays the strong association between HFRS category and specific adverse events. For example, the uOR of all-cause mortality risk was 5.30 (95% Confidence Interval [CI]: 2.20 to 12.78) with aOR 0.91 (95% CI: 0.37 to 2.21), 0.70 (95% CI: 0.62 to 0.78) with aOR 0.59 (95% CI: 0.53 to 0.66), 0.75 (95% CI: 0.55 to 1.03) with aOR 0.73 (95% CI: 0.53 to 1.00) for low, intermediate, and high risk procedures, respectively.  The uOR of ACE was 6.72 (95% CI: 5.86 to 7.71) with aOR 1.75 (95% CI: 1.39 to 2.22), 1.01 (95% CI: 0.97 to 1.04) with aOR 0.88 (95% CI: 0.84 to 0.91), 1.05 (95% CI: 0.95 to 1.16) with aOR 1.02 (95% CI: 0.92 to 1.13) for low, intermediate, and high risk procedures, respectively.  The uOR of DHN was 6.64 (95% CI: 5.72 to 7.62) with aOR 2.38 (95% CI: 1.97 to 2.87), 1.75 (95% CI: 1.71 to 1.80) with aOR 1.65 (95% CI: 1.60 to 1.69), 1.16 (95% CI: 1.07 to 1.25) with aOR 1.11 (95% CI: 1.02 to 1.20) for low, intermediate, and high-risk procedures, respectively.         
 

Conclusion: Frailty, as measured by HFRS, is prevalent in RA and strongly associated with adverse outcome. The use of this tool may serve an important role in preoperative assessment.

Supporting image 1

Figure 1. Hospital Frailty Score by Rheumatoid Arthritis Status

Supporting image 2

Table 1. Association Between HFRS with All-Cause Mortality and Adverse Outcomes: Stratified by Procedure Risk


Disclosures: A. Yazdanyar: None; J. Baker: CorEvitas, LLC, 2, Cumberland Pharma, 2, Formation Bio, 2, Horizon, 5; K. Wysham: None; M. Ward: None.

To cite this abstract in AMA style:

Yazdanyar A, Baker J, Wysham K, Ward M. Association Between Frailty and Peri-Operative Inpatient Adverse Outcomes Among Patients with and Without Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/association-between-frailty-and-peri-operative-inpatient-adverse-outcomes-among-patients-with-and-without-rheumatoid-arthritis/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-between-frailty-and-peri-operative-inpatient-adverse-outcomes-among-patients-with-and-without-rheumatoid-arthritis/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology